Sort
15,842 grants matching “pancreatic cancer”
Dietary fatty acids drive pancreatic cancer development
$130,812Mandar Deepak Muzumdar · Yale University · R01 · FY2025 · CA
Genetic Epidemiology of Young-Onset Pancreatic Cancer
$130,660Robert R McWilliams · Mayo Clinic Rochester · K07 · FY2006 · CA
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
$130,434Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · DE
P-1: Immunotherapy of Pancreatic Adenocarcinoma
$130,396Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2012 · CA
Administration and Communication
$130,391Scott E Kern · Johns Hopkins University · P50 · FY2015 · CA
The role of RalA in pancreatic tumorigenesis
$130,329Stephan Disean Kendall · Duke University · K08 · FY2011 · CA
The role of RalA in pancreatic tumorigenesis
$130,329Stephan Disean Kendall · Duke University · K08 · FY2012 · CA
The role of RalA in pancreatic tumorigenesis
$130,329Stephan Disean Kendall · Duke University · K08 · FY2008 · CA
The role of RalA in pancreatic tumorigenesis
$130,329Stephan Disean Kendall · Duke University · K08 · FY2010 · CA
Antiangiogenic therapy of pancreatic cancer
$130,329Beth Israel Deaconess Medical Center · K08 · FY2004 · CA
The role of RalA in pancreatic tumorigenesis
$130,329Stephan Disean Kendall · Duke University · K08 · FY2009 · CA
Antiangiogenic therapy of pancreatic cancer
$130,329Sareh Parangi · Beth Israel Deaconess Medical Center · K08 · FY2006 · CA
Antiangiogenic therapy of pancreatic cancer
$130,329Beth Israel Deaconess Medical Center · K08 · FY2003 · CA
Antiangiogenic therapy of pancreatic cancer
$130,329Beth Israel Deaconess Medical Center · K08 · FY2005 · CA
Hedgehog signaling in human hepatocellular carcinoma
$130,290University Of California San Francisco · R21 · FY2005 · CA
Targeted inhibition in stromal TGFβ activity in pancreatic cancer
$130,272Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2022 · CA
Developmental Program
$130,248Bert Vogelstein · Johns Hopkins University · P50 · FY2012 · CA
OUTREACH CORE
$130,241Folakemi T Odedina · University Of Florida · U54 · FY2020 · CA
NF-kB targets in the chemoresistance of GI malignancies
$130,216Hong Jin Kim · Univ Of North Carolina Chapel Hill · K08 · FY2007 · CA
NF-kB targets in the chemoresistance of GI malignancies
$130,216University Of North Carolina Chapel Hill · K08 · FY2004 · CA
NF-kB targets in the chemoresistance of GI malignancies
$130,216Hong Jin Kim · Univ Of North Carolina Chapel Hill · K08 · FY2006 · CA
NF-kB targets in the chemoresistance of GI malignancies
$130,216Hong Jin Kim · Univ Of North Carolina Chapel Hill · K08 · FY2008 · CA
NF-kB targets in the chemoresistance of GI malignancies
$130,216University Of North Carolina Chapel Hill · K08 · FY2005 · CA
Antiangiogenic therapy of pancreatic cancer
$130,209Beth Israel Deaconess Medical Center · K08 · FY2002 · CA
Analysis of zebrafish exocrine pancreas development
$130,194University Of Pennsylvania · K08 · FY2002 · DK